Memory Support System Feasibility Study

Condition(s) studied

Investigational drug(s) / intervention(s)

Memory Support System: The MSS is a two-page-per-day, pocket-sized calendar/note-taking system with three sections: (a) events; (b) to do's; and (c) journaling for logging important things to be remembered (e.g., news about family/friends). MSS training consists of ten 1-hour sessions delivered over two or six weeks, starting 7-10 days after baseline assessment.

Study summary

The purpose of this study is to determining the feasibility of providing the Memory Support System (MSS) to individuals with mild cognitive impairment (MCI) and their partners at a clinic in Ontario, Canada. This will involve a) collecting information from patients referred to the a memory clinic and geriatric day hospital about the patient's interest in and the patient's preferred method to administer the MSS; and b) a cost analysis related to implementation of the MSS. The study will also measure efficacy outcomes of the MSS regarding program adherence as well as to self-reported IADLs, self-efficacy for memory, quality of life, mood, anxiety, and caregiver burden among a sample of individuals with MCI and their care partners

Eligibility

Primary outcome measure(s)

• Interest in completion of MSS training — From study start date up to 19 months.
  Percentage of participants that complete the feasibility survey and agree or strongly agree with the statement that they are interested in completing MSS training.

Trial sites (1)

More Bruyère Health Research Institute. trials in Canada

Other trials for the same condition